Ephedrine‐Induced Cardiac Ischemia: Exposure Confirmed with a Serum Level

  title={Ephedrine‐Induced Cardiac Ischemia: Exposure Confirmed with a Serum Level},
  author={J. Schier and S. Traub and R. Hoffman and L. Nelson},
  journal={Journal of Toxicology: Clinical Toxicology},
  pages={849 - 853}
Abstract The temporal association of symptoms consistent with ephedrine toxicity after ingestion of ephedrine‐containing dietary supplements is heavily relied upon to confirm exposure. Few reports in the literature attempt to associate toxicity with serum levels of these drugs. We report a case of ephedrine‐induced cardiac ischemia confirmed by a plasma level. A 22‐year‐old woman ingesting an ephedrine‐ and caffeine‐containing product for 2 days presented with multiple symptoms, including… Expand
10 Citations
A beating heart cell model to predict cardiotoxicity: effects of the dietary supplement ingredients higenamine, phenylethylamine, ephedrine and caffeine.
  • 15
  • Highly Influenced
Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.
  • 23
Pathology of emesis: its autonomic basis.
  • W. Hasler
  • Medicine
  • Handbook of clinical neurology
  • 2013
  • 15
Short‐term Metabolic and Hemodynamic Effects of Ephedra and Guarana Combinations
  • 63
28 Days repeated oral dose toxicity test of aqueous extracts of mahwangyounpae-tang, a polyherbal formula.
  • 36


Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang).
  • 83
Pharmacokinetics and Cardiovascular Effects of Ma‐Huang (Ephedra sinica) in Normotensive Adults
  • 128
  • Highly Influential
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
  • 277
  • Highly Influential
Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography.
  • 107
  • PDF
Ephedrine abuse causing acute myocardial infarction
  • 42
Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects
  • 16
The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatment.
  • 28
  • PDF
Content versus label claims in ephedra-containing dietary supplements.
  • B. Gurley, S. Gardner, M. Hubbard
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2000
  • 221
  • PDF
Pharmacology of ephedra alkaloids and caffeine after single‐dose dietary supplement use
  • 103